Source of Support: None, Conflict of Interest: None
Thirty-one asthmatic patients from a general hospital were taken up for the study. Patients were randomly assigned to either TEP-SA one tablet B.I.D. or salbutamol 4 mg T.I.D. After two weeks of therapy the patients were switched over to the second drug. Patients were assessed on 8th, 15th, 22nd and 29th day of treatment. Results showed TEP-SA and salbutamol both significantly reduced the number of attacks and increased PEFR over pretreatment values. Statistical evaluation of difference in respect to all the parameters of assessment between the two drugs was not significant. Both the drugs were equally well tolerated by all the patients.